Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
FIND Celebrates History-Making Achievement by WHO Member States Following Consensus on a proposed Pandemic Accord In the early hours of Wednesday of 16 April, WHO member states working with the WHO Secretariat and the Intergovernmental Negotiating Body (INB) reached consensus over a draft agreement for the proposed Pandemic Accord.
DxConnect test directory Searchable directory of diagnostic tests for various diseases under the DxConnect umbrella.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
FIND Celebrates History-Making Achievement by WHO Member States Following Consensus on a proposed Pandemic Accord In the early hours of Wednesday of 16 April, WHO member states working with the WHO Secretariat and the Intergovernmental Negotiating Body (INB) reached consensus over a draft agreement for the proposed Pandemic Accord. FIND 16 Apr 2025
Swiss Government’s State Secretariat for Education, Research and Innovation (SERI) Awards 5-Year Grant to FIND for Innovative Malaria Testing FIND 10 Apr 2025
Dr. Ifedayo Adetifa on NTDs, Cervical Cancer & Africa’s Pandemic Preparedness Adonis Byemelwa 17 Feb 2025
Diagnostics & the Nagoya Protocol The Nagoya protocol is an international agreement, supplementary to the United Nations Convention on Biological Diversity.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease or infection in a defined geographic area, as a result of deliberate efforts.
Diagnostics & trade finance Trade finance is a term that describes the financial instruments and products used by companies to facilitate international trade and commerce.
Diagnostics & intellectual property The pharmaceutical and vaccine industries both make regular use of patents to protect their innovative products. The situation for diagnostics is less straightforward; in many cases, patents are less consequential for diagnostics than for other health products.
Diagnostics & vaccines The benefits of vaccines are well known. However, vaccines cannot be developed, tested, targeted, or used efficiently and effectively without diagnostics. This document explains how diagnostics are a critical enabler for vaccines.
